A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis.
Yin J, Zhao M, Xu X, Zhang M, Xu Z, Li Z, Qin X, Li Z, Zhao C, Zhou H, Ma Y, Cao W, Wang G, Lin Y, Zhang J, Zhang X, Cai H, Qian W, Wang Y, Zhang X, Liu G, Wang J, Qiu W, Min L, Li J, Deng H, Chu L, Zhang Y, Fang J.
Yin J, et al. Among authors: zhang m, zhang j, zhang x, zhang y.
Eur J Neurol. 2024 Aug;31(8):e16322. doi: 10.1111/ene.16322. Epub 2024 May 10.
Eur J Neurol. 2024.
PMID: 38726639
Free PMC article.
Clinical Trial.